As HIV prevention evolves, long-acting injectable options like lenacapavir are emerging as promising tools to expand access and adherence. Effective implementation of new interventions calls for thoughtful planning across key areas, including operations, staffing, finance, and patient access. Join our expert faculty for a webinar on Thursday, September 18, 2025, 1:00 PM Eastern designed for clinic administrators and pharmacists. The “Operationalizing Lenacapavir for PrEP in Your Health Systems” webinar is the third webinar in the “Revolutionizing HIV Prevention” SYNChronicity webinar series.

This session will walk through the essential considerations for integrating lenacapavir into practice, including:

• Business Planning: Building leadership buy-in, adapting existing long-acting PrEP delivery models, assessing staffing needs, and programming EHR/EMR systems.
• Reimbursement Strategies: Evaluating buy-and-bill feasibility, 340B program considerations, insurance coverage, billing processes, and patient access/privacy safeguards.
• Site of Care & Administration: Navigating lead-in doses, injection procedures, and day-to-day operational logistics.

The webinar will feature expert-led presentations and a live Q&A to support understanding and real-world use. Participants will leave with actionable insights into how to prepare their organizations for lenacapavir implementation and ensure sustainability in delivery.

Continuing education credits are not available for this webinar. This series is supported by Gilead who provided funding. Gilead has had no input into the content of the materials used at this event.

Related Events

• 

  SYNC 2026

  March 18, 2026 – March 20, 2026